Author: | Straus, D. |
Article Title: | Comparative studies on erythropoietic agents |
Abstract: | A variety of studies have shown that epoetins significantly increase hemoglobin levels, decrease transfusion requirements, and improve quality of life in patients with chemotherapy-related anemia. However, despite guidelines recommendations, patients may still be under treated. © Journal of the National Comprehensive Cancer Network. |
Keywords: | cancer chemotherapy; unclassified drug; antianemic agent; clinical trial; dose response; antineoplastic agents; conference paper; antineoplastic agent; clinical practice; quality of life; erythropoietin; anemia; lung non small cell cancer; drug administration schedule; hemoglobin; practice guideline; b cell lymphoma; hematologic malignancy; nonhodgkin lymphoma; chemically induced disorder; hematologic malignancies; carcinoma; drug derivative; drug administration; recombinant erythropoietin; novel erythropoiesis stimulating protein; hematinics; epoetin alfa; chemotherapy-related anemia; erythropoiesis receptor activator; fg 2216 |
Journal Title: | Journal of the National Comprehensive Cancer Network |
Volume: | 3 |
Issue: | SUPPL. 1 |
ISSN: | 1540-1405 |
Publisher: | Harborside Press |
Date Published: | 2005-11-01 |
Start Page: | S |
End Page: | 46 |
Language: | English |
PUBMED: | 16280113 |
PROVIDER: | scopus |
DOI/URL: | |
Notes: | --- - "Export Date: 24 October 2012" - "Source: Scopus" |